Asian Journal of Urology is a premier open-access scholarly journal dedicated to advancing the field of urology. Published by Elsevier Singapore Pte Ltd, this journal provides a platform for researchers, clinicians, and students to share impactful findings and innovative practices within urological sciences. Since its inception in 2014, it has established itself as a significant contributor to the discourse in urology, achieving a commendable Q2 ranking in the category of Urology for 2023 and securing the 41st position out of 120 in Scopus rankings, placing it in the 66th percentile amongst its peers. With a commitment to ensuring broad accessibility, all articles are freely available online, promoting widespread dissemination of knowledge. The journal aims to publish high-quality research that informs clinical practices and contributes to the development of urological sciences, making it an essential resource for professionals and scholars in the field.

The Journal of Urology stands as a premier publication in the field of urology, dedicated to advancing the understanding and treatment of urological diseases. Published by Lippincott Williams & Wilkins, this esteemed journal has maintained a strong presence since its inception in 1945, converging research and clinical practice until 2024. With an impressive impact factor that underscores its relevance and influence in the field—ranking 4th out of 120 in Urology according to Scopus—this journal is a vital resource for clinicians, researchers, and students alike. As a Q1 journal in its category for 2023, it boasts a high degree of visibility and rigorous peer-review standards, making it an essential reading for those wishing to stay abreast of the latest discoveries and technological advancements in urological health. Although it does not offer open access, the journal's commitment to disseminating high-quality research ensures its continued impact on both the academic community and clinical practice.

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.

ARCHIVOS ESPANOLES DE UROLOGIA, published by INIESTARES, S.A., serves as a key academic resource for urology and related medical fields. With an impressive history dating back to 1945, this journal has evolved to address the ongoing advancements and challenges in the field of urology, making crucial contributions to medical knowledge and practice. Although classified in category quartile Q3 for Urology and Q4 for Medicine (miscellaneous), the journal's commitment to quality research is reflected in its diverse range of topics, which are geared toward practitioners, researchers, and students alike. While it does not currently operate under an open access model, the insights and findings presented in its articles are indispensable for anyone looking to deepen their understanding of urological medicine. With a Scopus rank of #84 out of 120 in Urology, this journal continues to be an essential platform for disseminating significant research and fostering academic dialogue in the Spanish medical community and beyond.

WORLD JOURNAL OF UROLOGY, published by Springer, stands as a premier journal in the field of urology, holding a commendable Q1 ranking in the 2023 category quartiles. With an ISSN of 0724-4983 and an E-ISSN of 1433-8726, this journal has been a vital resource since its inception in 1983, and continues to influence research up to 2024. Its ranking of 13th out of 120 in the Scopus Medicine Urology category, placing it in the 89th percentile, reflects its significant impact within the academic community. The journal aims to publish cutting-edge research, reviews, and clinical studies that advance knowledge in urological science and practice. Although it features no open access options, its rigorous peer-review process ensures that only the highest quality studies are disseminated, catering to a wide audience of researchers, medical professionals, and students eager to stay at the forefront of urological advancements.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

Research and Reports in Urology, published by DOVE MEDICAL PRESS LTD, is a premier journal dedicated to the dissemination of cutting-edge research and clinical advancements in the field of urology. With an impressive impact factor and a recognized status as Q2 within the urology category, this journal offers a vital platform for researchers, practitioners, and students eager to engage with the latest findings and methodologies. Since its inception in 2009, the journal has embraced an Open Access model, ensuring that critical research is freely available to the global community, thereby fostering collaboration and innovation in urological science. Based in New Zealand, it operates within a robust international framework, allowing for a diverse range of contributions that address pressing issues in urology and enhance professional knowledge. Researchers are encouraged to submit their work and become part of this influential discourse, as the journal continues to navigate the rapidly evolving landscape of urological health from 2012 to 2024 and beyond.

Urological Science, published by Lippincott Williams & Wilkins, is a prominent open-access journal that has been a vital resource for the Urology field since its establishment in 2010. With a focus on innovative research and advancements in urological science, the journal aims to disseminate significant findings and encourage dialogue among physicians, researchers, and healthcare professionals worldwide. The journal has achieved a commendable Q3 rank within its category according to the latest quartiles released in 2023 and holds a Scopus rank of #80 out of 120 in the Medicine Urology field, placing it in the 33rd percentile. By providing an open-access platform, Urological Science ensures that vital research is easily accessible to a global audience, supporting the ongoing advancements in urological healthcare and education. As the landscape of urology evolves, this journal remains an essential vehicle for sharing knowledge and improving patient outcomes, making it an invaluable resource for anyone invested in the future of urological science.

Therapeutic Advances in Urology is a distinguished, peer-reviewed journal published by SAGE Publications Ltd, dedicated to disseminating groundbreaking research and advancements in the field of urology. With an impressive impact factor and classified in the Q2 category for Urology as of 2023, this journal plays a critical role in advancing knowledge and clinical practices related to urological diseases and therapies. Since its establishment in 2009, the journal has transitioned to an Open Access format as of 2019, ensuring that vital research findings are freely available to researchers, healthcare professionals, and students worldwide. The journal is ranked #44 out of 120 in the Medicine - Urology category within Scopus, reflecting its commitment to high-quality, impactful scholarship. Whether you are seeking to keep abreast of the latest therapeutic innovations or contribute to the evolving discourse in urology, Therapeutic Advances in Urology is an essential resource for those passionate about improving patient outcomes and advancing clinical practices.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.